These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods. Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245 [TBL] [Abstract][Full Text] [Related]
6. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites]. Rieder H; Ramadori G; Meyer zum Büschenfelde KH Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224 [TBL] [Abstract][Full Text] [Related]
9. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy. Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195 [TBL] [Abstract][Full Text] [Related]
10. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585 [TBL] [Abstract][Full Text] [Related]
11. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis. Khan FY Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102 [TBL] [Abstract][Full Text] [Related]
12. [Biochemical markers of the tumor origin of ascites]. Romette J; di Costanzo-Dufetel J Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823 [TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen gradients between plasma and malignant ascites: use in detecting peritoneal and liver metastases. Loewenstein MS; Rittgers RA; Kupchik HZ; Zamcheck N J Natl Cancer Inst; 1981 May; 66(5):803-6. PubMed ID: 6939926 [TBL] [Abstract][Full Text] [Related]
16. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure]. Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885 [TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers. Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727 [TBL] [Abstract][Full Text] [Related]
18. [Detection of polyamines by a new enzymatic differential assay. (8) Studies on tissue polyamine concentrations in patients with genitourinary malignant diseases]. Koide T; Sakai S; Kawada Y; Hara A; Sawada H Hinyokika Kiyo; 1990 Oct; 36(10):1109-16. PubMed ID: 2264538 [TBL] [Abstract][Full Text] [Related]
19. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Tangkijvanich P; Tresukosol D; Sampatanukul P; Sakdikul S; Voravud N; Mahachai V; Mutirangura A Clin Cancer Res; 1999 Sep; 5(9):2470-5. PubMed ID: 10499621 [TBL] [Abstract][Full Text] [Related]
20. Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis. Bandyopadhyay R; Bandyopadhyay SK; Ghosal J; Kumar U; Dutta A J Indian Med Assoc; 2006 Apr; 104(4):174, 176-7, 185. PubMed ID: 16910322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]